Abstract
Purpose: To investigate the impact of nasal septal deviation and septoplasty on dacryocystorhinostomy progression.Methods: From March 2015 to January 2022, we reviewed the medical records of primary acquired nasolacrimal duct obstruction (PANDO) patients who underwent dacryocystorhinostomy at Konyang University Hospital. Patients were categorized into groups: those without septal deviation (group 1), those with septal deviation on the same side as the surgical site (group 2), and those with septal deviation on the opposite side (group 3). Septoplasty was performed in cases of symptomatic septal deviation on the same side. We assessed whether the presence, type, and correction of septal deviation influenced the postoperative outcome of dacryocystorhinostomy.Results: The study included 204 patients: 94 in group 1, 60 in group 2, and 50 in group 3. No significant differences were observed in the type, degree of nasal septum deviation, surgery duration, success rate, and symptom improvement period across the groups. When group 2 was subdivided into those who did not undergo septoplasty (group 2A) and those who did (group 2B), no differences were noted.Conclusions: Nasal septum deviation and septoplasty did not influence the outcomes of dacryocystorhinostomy. Septoplasty may be unnecessary for PANDO patients without symptomatic nasal septum deviation.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call